Genic Co., Ltd. (KOSDAQ:123330)
24,100
-200 (-0.82%)
At close: Sep 23, 2026
Genic Market Cap
Genic has a market cap or net worth of 188.57 billion as of September 24, 2026. Its market cap has decreased by -14.69% in one year.
Market Cap
188.57B
Enterprise Value
190.41B
Revenue
114.29B
Ranking
n/a
PE Ratio
7.23
Stock Price
24,100.00
ChartMarket Cap Chart
Since August 3, 2011, Genic's market cap has increased from 160.45B to 188.57B, an increase of 17.53%. That is a compound annual growth rate of 1.07%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 23, 2026 | 188.57B | 45.88% |
| Dec 30, 2025 | 129.26B | -28.02% |
| Dec 30, 2024 | 179.58B | 627.57% |
| Dec 28, 2023 | 24.68B | -18.18% |
| Dec 29, 2022 | 30.17B | -28.80% |
| Dec 30, 2021 | 42.37B | 68.16% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| C&C International | 294.13B |
| Manyo Factory | 256.06B |
| CLIO Cosmetics Co.,Ltd | 213.45B |
| Englewood Lab | 162.92B |
| Aromatica | 143.75B |
| BBIA Co., Ltd. | 69.55B |
| Icure Pharmaceutical Incorporation | 66.52B |
| Raphas | 64.32B |